p53 as a potential target in cancer therapy.
Ozturk
M
M
MGH Cancer Center, Charlestown.
Ponchel
F
F
Puisieux
A
A
D001323:Autoantibodies / Q000276:immunology; D014408:Biomarkers, Tumor / Q000235:genetics; D005787:Gene Frequency; D016158:Genes, p53; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D014162:Transfection; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency / Q000235:genetics* / Q000276:immunology / Q000627:therapeutic use
D001323:Autoantibodies; D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D011994:Recombinant Proteins; D016159:Tumor Suppressor Protein p53